InsidersTradesSigma
立方制药: directors' dealings · France · AMF
SZSE:003020FR·AMFMcap 4.9Bn€
Explore the full insider trade history of 立方制药, a listed equity based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €4.9bn. The latest transaction was reported on 21 June 2023 (Sale). Among the most active insiders: 汪琴. All data is openly available.
11
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
11 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
21.21 €
Income statement
Revenue1.55 Bn€
Gross profit1.00 Bn€65% margin
Net income165.2 M€10.6% margin
Balance sheet & cash
Market cap4.92 Bn€
Total debt63.9 M€
Free Cash Flow94.4 M€
Last declaration on 21 June 2023
Declarations11 total
11 of 11 declarations